Your browser doesn't support javascript.
loading
Prognostic significance of HER-2, p53 and Bcl-2 in patients with epithelial ovarian cancer.
Malamou-Mitsi, Vassiliki; Crikoni, Olga; Timotheadou, Eleni; Aravantinos, Gerassimos; Vrettou, Eleni; Agnantis, Niki; Fountzilas, George.
Affiliation
  • Malamou-Mitsi V; Department of Pathology, University of Ioannina School of Medicine, Ioannina, Greece. vmalamou@cc.uoi.gr
Anticancer Res ; 27(2): 1157-65, 2007.
Article in En | MEDLINE | ID: mdl-17465257
Subject(s)
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Tumor Suppressor Protein p53 / Receptor, ErbB-2 / Proto-Oncogene Proteins c-bcl-2 Type of study: Clinical_trials / Prognostic_studies Limits: Adult / Aged / Female / Humans / Middle aged Language: En Journal: Anticancer Res Year: 2007 Document type: Article Affiliation country: Greece Country of publication: Greece
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Tumor Suppressor Protein p53 / Receptor, ErbB-2 / Proto-Oncogene Proteins c-bcl-2 Type of study: Clinical_trials / Prognostic_studies Limits: Adult / Aged / Female / Humans / Middle aged Language: En Journal: Anticancer Res Year: 2007 Document type: Article Affiliation country: Greece Country of publication: Greece